Trial Design

INSIGHTS ON CLINICAL TRIAL DESIGN

At-Home Clinical Trials: When At-Home Ophthalmic Exams Make Sense
At-home ophthalmic exams in clinical trials improve patient accessibility, reduce site burden, and maintain data integrity, enabling decentralized research without sacrificing quality or compliance.
Providing Clinical Trial Patients With Transportation

Explore how thoughtful, well-supported transportation strategies can reduce barriers, enhance participant retention, and strengthen the overall success of clinical trials.
How To Improve Patient ID And Retention In Chronic Disease Trials
Leveraging primary care for chronic disease studies can accelerate patient identification, access to underrepresented populations, and improve retention rates.
Why We Need To Look To The Future Of Clinical Trials
Explore how decentralized trial elements, community-focused site networks, and patient-centric infrastructure can improve recruitment, data quality, equity, and efficiency.

How To Reduce Eligibility Risk And Prevent Protocol Deviations
3/18/2026

Eliminate enrollment-based protocol deviations and align with the latest FDA guidance by implementing a centralized, technology-enabled eligibility review to safeguard trial integrity.
Why Bioanalysis Needs To Break Free From Manual Bottlenecks
9/2/2025

Bioanalysis remains one of the most persistent bottlenecks in drug development, with CROs displaying inefficiencies that are no longer operational nuisances but strategic liabilities.
Wearable Data Is Only Useful If It's There: Helping You Collect Your Study Data
9/15/2025

New, proactive alerts on this digital health platform ensure complete and high-quality data collection from wearable devices in clinical trials.
Mastering Scope 3 Emissions In Clinical Trials
10/23/2024

Explore innovative strategies for reducing Scope 3 emissions in clinical trials. Discover sustainable solutions that uphold quality and outcomes, crucial for achieving net-zero goals in healthcare research.
5 Proven Ways To Expand Clinical Trial Site Capacity
9/18/2025

How can you turn capacity limits into enrollment momentum and ensure timelines stay on track while also expanding access to diverse patient populations?

Human Abuse Potential

With over 60 HAP studies successfully conducted in the last decade, Altasciences has experience in diverse areas such as for stimulants, opioids, and sedative-hypnotics.
Ergomed's Patient-Centric Focus Drives Our Team

Ergomed places patients and their care partners’ needs at the core of our services. We strive to build empathetic relationships with patients and their care partners, not just during the trial but also before and after. Our team provides personalized support, aiming to alleviate the burden of study participation. Ergomed and our trusted partners are deeply committed to bringing lifesaving treatments to patients.
Dynamic RTSM Featuring Configurable, Pre-Validated Components

Your trusted RTSM solution, PULSE is designed to support all study designs with configurable, pre-validated components. PULSE empowers study teams to easily manage randomization and trial supply workflows with flexibility and precision.
TrialScope Disclose

With TrialScope Disclose, study sponsors streamline and optimize the entire clinical trial disclosure process from initial registration to final results — mitigating risk, maximizing transparency and ultimately moving healthcare forward.
Castor Professional Services: Your Trial Delivery Partner

Accelerate clinical trial timelines and ensure audit-readiness with expert-led build models, AI-driven data management, and global participant support designed to streamline your path to submission.